YD Bio (YDES) Total Non-Current Liabilities (2024 - 2026)
YD Bio's (YDES) quarterly Total Non-Current Liabilities came in at $1.1 million in Q2 2026, down 34.97% quarter-over-quarter from $1.6 million in Q4 2025.
Powered by 
Analysis
YD Bio (YDES) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends
YD Bio (YDES) has reported Total Non-Current Liabilities for 3 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $1.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.6 million, down 99.4% from the prior year.
- Total Non-Current Liabilities was $1.1 million for Q2 2026 at YD Bio, down from $1.6 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $274.0 million in Q4 2024 and troughed at $1.1 million in Q2 2026.
- A 3-year average of $92.2 million and a median of $1.6 million in 2025 frame the typical range for Total Non-Current Liabilities.
- The widest YoY moves for Total Non-Current Liabilities: up 99.4% in 2025, down 99.4% in 2025.
- Over 3 years, Total Non-Current Liabilities stood at $274.0 million in 2024, then sank by 99.4% to $1.6 million in 2025, then sank by 34.97% to $1.1 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $1.1 million (Q2 2026), $1.6 million (Q4 2025), and $274.0 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 81.11 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 36.04 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 5.92 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 7.74 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 3.92 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 40.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 12.42 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 378.37 Mn |
| 10 | YD Bio | 225.82 Mn | 223.16 Mn | - | 1.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 273.98 Mn |
API Access
YD Bio Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=YDES&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "YDES", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=YDES&period=max&api_key=YOUR_API_KEY");
const data = await res.json();